Quick Takeaways Retatrutide is a triple-receptor agonist (GLP-1, GIP, glucagon) delivering superior monotherapy weight loss at 2428.7% over 4868 weeks Cagrilintide targets amylin receptors for satiety and gastric emptying, achieving 10.8% weight loss in 26 weeks as a monotherapy Retatrutide provides broader metabolic benefits, including dramatic improvements in HbA1c, blood pressure, waist circumference, insulin sensitivity, and liver fat normalization No head-to-head trials exist yet, but the mechanistic and clinical data strongly favor Retatrutide for total body recomposition Retatrutide vs Cagrilintide: Side-by-Side Comparison What Makes Retatrutide Different Retatrutide isnt just another GLP-1 receptor agonist
Lipid Derivatives: Why Standard Wins GHK-Cu is available in various forms, including its standard water-soluble form and lipid derivatives like palmitoyl-GHK (Pal-GHK) , which are modified with fatty acids to enhance skin penetration
Loo A, Mackus M, Kwon O, et
Theres some evidence that the most beneficial form of NAD may be nicotinamide riboside (NR) thanks to its bioavailabilityand therefore its ability to increase NAD levels